1
PDGFB may serve as a potential interest of therapeutic regulators in patients with metastatic NPC.
2
Background: The current treatment strategy for bone metastatic NPC patients was empirically given and poorly studied before.
3
Materials and methods: Patients with newly-diagnosed, non-distant metastatic NPC from two centers were enrolled in this study.
4
Conclusions: Radiotherapy to metastatic bones with palliative dose prescription should not be considered in bone metastatic NPC patients.
5
The present study aimed to investigate the prognostic value of pretreatment LMR in a large cohort of metastatic NPC patients.
6
Methods: Clinical data of 672 patients with metastatic NPC diagnosed between January 2003 and December 2009 were analyzed.